Long COVID Trial, Recruiting NCT06865222 Sponsor: Mayo Clinic Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT06865222
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have recently had COVID-19 and are being seen at the Post COVID-19 Clinic at Mayo Clinic Rochester.
  • You have had at least one of these ongoing symptoms for more than 4 weeks after your first positive COVID-19 test: loss of smell, ringing in the ears (tinnitus), or significant fatigue.
  • Your loss of smell must be confirmed by a smell test showing reduced or absent smell ability.
  • Your ringing in the ears must have started after your COVID-19 infection and be confirmed by a standard questionnaire score above zero.
  • Your fatigue must score 40 or above on a standard fatigue questionnaire called the Modified Fatigue Impact Scale.

Who may not be able to join:

  • You have an implanted electronic device, such as a pacemaker, defibrillator, medication pump, or vagus nerve stimulator.
  • You drink more than 14 alcoholic drinks per week, have a formal diagnosis of alcohol abuse, or use illegal drugs.
  • You have had a seizure at any point in the last 10 years.
  • You have any metal implants in or near your head, such as aneurysm clips, brain stimulators, cochlear implants, or stents (confirm with trial site if unsure).
  • You are currently enrolled in, or planning to join, another clinical trial that involves a treatment or intervention.
  • You have previously had a stroke that left lasting effects.
  • You are unable to understand or follow spoken instructions.
  • You are unable to understand and sign a consent form for the study.
  • Your doctor feels that your medical condition means you would not be able to safely take part in the trial procedures.
  • You have an unstable or significant medical condition that the researchers feel could put you at risk or affect the study results (confirm with trial site).
  • You are pregnant or trying to become pregnant; women who could potentially be pregnant will need a negative pregnancy test at the start of the study.
  • You have any other condition that, in the researchers' judgment, would prevent you from completing the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ryan T. Hurt, M.D., Mayo Clinic

Phone: 507-266-1944

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
22 July 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in University of Pennsylvania Smell Identification Test (UPSIT) Olfactory Threshold Test score; Change in Tinnitus Handicap Inventory Scale score; Change in Modified Fatigue Impact Scale score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov